Protective Effects of Eicosapentaenoic Acid Plus Hydroxytyrosol Supplementation Against White Adipose Tissue Abnormalities in Mice Fed a High-Fat Diet.


Journal

Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009

Informations de publication

Date de publication:
27 Sep 2020
Historique:
received: 27 08 2020
revised: 16 09 2020
accepted: 20 09 2020
entrez: 30 9 2020
pubmed: 1 10 2020
medline: 19 3 2021
Statut: epublish

Résumé

Obesity induced by high-fat diet (HFD) elicits white adipose tissue dysfunction. In this study, we have hypothesized that the metabolic modulator eicosapentaenoic acid (EPA) combined with the antioxidant hydroxytyrosol (HT) attenuates HFD-induced white adipose tissue (WAT) alterations. C57BL/6J mice were administered with a HFD (60% fat, 20% protein, 20% carbohydrates) or control diet (CD; 10% fat, 20% protein, 70% carbohydrates), with or without EPA (50 mg/kg/day), HT (5 mg/kg/day), or both for 12 weeks. Determinations in WAT include morphological parameters, EPA and docosahexaenoic acid content in phospholipids (gas chromatography), lipogenesis, oxidative stress (OS) and inflammation markers, and gene expression and activities of transcription factors, such as sterol regulatory element-binding protein-1c (SREBP-1c), peroxisome proliferator-activated receptor-gamma (PPAR-γ), nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) (p65 subunit) and nuclear factor erythroid 2-related factor 2 (Nrf2) (quantitative polymerase chain reaction and enzyme linked immunosorbent assay). HFD led to WAT hypertrophy in relation to PPAR-γ downregulation. WAT metabolic dysfunction was characterized by upregulation of lipogenic SREBP-1c system, mitochondrial energy metabolism depression, loss of the antioxidant Nrf2 signaling with OS enhancement, n-3 long-chain polyunsaturated fatty acids depletion and activation of the pro-inflammatory NF-κB system. EPA and HT co-supplementation diminished HFD-dependent effects additively, reaching values close or similar to controls. Data presented strengthen the importance of combined protocols such as EPA plus HT to attenuate metabolic-inflammatory states triggered by obesity.

Identifiants

pubmed: 32992508
pii: molecules25194433
doi: 10.3390/molecules25194433
pmc: PMC7582637
pii:
doi:

Substances chimiques

3,4-dihydroxyphenylethanol 10597-60-1
Eicosapentaenoic Acid AAN7QOV9EA
Phenylethyl Alcohol ML9LGA7468

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Fondo Nacional de Desarrollo Científico y Tecnológico
ID : 11140174
Organisme : Fondo Nacional de Desarrollo Científico y Tecnológico
ID : 1181774

Références

Lipids. 2004 Dec;39(12):1177-85
pubmed: 15736913
J Vis Exp. 2012 Apr 20;(62):
pubmed: 22546956
Free Radic Biol Med. 2019 Sep;141:393-407
pubmed: 31279968
Nucleic Acids Res. 2001 May 1;29(9):e45
pubmed: 11328886
Pharmacol Res. 2018 Jun;132:168-175
pubmed: 29253525
Int J Mol Sci. 2017 Apr 28;18(5):
pubmed: 28452954
Acta Pharmacol Sin. 2012 Feb;33(2):173-81
pubmed: 22301857
Nutrition. 2010 Feb;26(2):209-17
pubmed: 19665871
Proc Natl Acad Sci U S A. 1964 Nov;52:1255-63
pubmed: 14231450
Nutr Metab (Lond). 2016 Oct 4;13:65
pubmed: 27708685
Food Funct. 2017 Apr 19;8(4):1526-1537
pubmed: 28386616
Biochem Soc Trans. 2017 Oct 15;45(5):1105-1115
pubmed: 28900017
Can J Biochem Physiol. 1959 Aug;37(8):911-7
pubmed: 13671378
Proc Nutr Soc. 2010 Aug;69(3):324-32
pubmed: 20540825
Hepatology. 2010 Feb;51(2):679-89
pubmed: 20041406
Biochem Biophys Res Commun. 2013 Jan 4;430(1):225-30
pubmed: 23131562
FASEB J. 2009 Jun;23(6):1946-57
pubmed: 19211925
Metabolism. 2019 Mar;92:6-10
pubmed: 30253139
Nutrients. 2020 Feb 15;12(2):
pubmed: 32075238
J Biol Chem. 1964 Feb;239:375-80
pubmed: 14169133
Endocr Metab Immune Disord Drug Targets. 2018;18(1):85-93
pubmed: 29149822
Nutr Metab Cardiovasc Dis. 2014 Oct;24(10):1144-50
pubmed: 24984826
Front Physiol. 2020 Jan 22;10:1638
pubmed: 32038305
Free Radic Biol Med. 2014 Feb;67:396-407
pubmed: 24316371
Food Funct. 2019 Sep 1;10(9):6170-6183
pubmed: 31501836
J Nutr. 2010 Nov;140(11):1915-22
pubmed: 20861209
Biochem Biophys Res Commun. 1979 Nov 14;91(1):272-7
pubmed: 518626
Food Chem Toxicol. 2013 Dec;62:869-75
pubmed: 24157545
Diabetologia. 2009 May;52(5):941-51
pubmed: 19277604
Am J Physiol. 1971 Sep;221(3):850-8
pubmed: 5570342
N Engl J Med. 2017 Jul 6;377(1):13-27
pubmed: 28604169
J Biol Chem. 1957 May;226(1):497-509
pubmed: 13428781
Nat Commun. 2016 Nov 17;7:13479
pubmed: 27853148
Nutr Metab (Lond). 2017 May 8;14:33
pubmed: 28503189
Lipids Health Dis. 2017 Apr 11;16(1):64
pubmed: 28395666
Mol Aspects Med. 2018 Dec;64:147-160
pubmed: 29329795
Nat Protoc. 2006;1(6):3159-65
pubmed: 17406579
Obesity (Silver Spring). 2020 Jul;28(7):1187-1190
pubmed: 32339391
Br J Nutr. 2007 Feb;97(2):389-98
pubmed: 17298710
Sci Rep. 2019 Sep 10;9(1):12978
pubmed: 31506475
Mol Aspects Med. 2013 Apr-Jun;34(2-3):516-28
pubmed: 23506886
J Cell Biol. 2015 Mar 2;208(5):501-12
pubmed: 25733711
J Diabetes Investig. 2019 May;10(3):602-612
pubmed: 30216708
Oxid Med Cell Longev. 2018 Jul 2;2018:5109503
pubmed: 30057681
Diabetologia. 2006 Feb;49(2):394-7
pubmed: 16397791
Nat Rev Endocrinol. 2019 May;15(5):288-298
pubmed: 30814686
Arterioscler Thromb Vasc Biol. 2007 Sep;27(9):1918-25
pubmed: 17569885
Clin Chem. 2008 Jun;54(6):945-55
pubmed: 18436717
Mol Aspects Med. 2018 Dec;64:92-108
pubmed: 28887275
Clin Sci (Lond). 2009 Aug 14;117(6):243-9
pubmed: 19296827
Curr Med Chem. 2020;27(31):5250-5272
pubmed: 30968772
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
Curr Opin Nephrol Hypertens. 2020 Mar;29(2):171-179
pubmed: 31815758
Proc Nutr Soc. 2009 Nov;68(4):361-9
pubmed: 19698199
Biomed Pharmacother. 2019 Jan;109:2472-2481
pubmed: 30551508
Diabetes. 2007 Jul;56(7):1751-60
pubmed: 17456854
Cell Mol Life Sci. 2017 Aug;74(15):2723-2733
pubmed: 28285320
Food Funct. 2011 Nov;2(11):644-8
pubmed: 22008843
Br J Nutr. 2019 Aug 28;122(4):423-430
pubmed: 31309919
Prostaglandins Leukot Essent Fatty Acids. 2015 Jul;98:7-14
pubmed: 25910408
Cell. 2010 Sep 3;142(5):687-98
pubmed: 20813258
J Nutr. 2015 Mar;145(3):411-7
pubmed: 25733455
J Nutr Biochem. 2019 Jan;63:35-43
pubmed: 30321750
Eur J Clin Nutr. 2013 Dec;67(12):1234-42
pubmed: 24129365
Biochim Biophys Acta Mol Cell Biol Lipids. 2018 Dec;1863(12):1523-1531
pubmed: 30261280
Physiol Rep. 2017 Apr;5(7):
pubmed: 28400497
Mol Nutr Food Res. 2017 Dec;61(12):
pubmed: 28940752
Cell Metab. 2016 May 10;23(5):770-84
pubmed: 27166942

Auteurs

Paola Illesca (P)

Laboratory of Studies of Metabolic Diseases Related to Nutrition. Faculty of Biochemistry. University of Litoral, Santa Fe 3000, Argentina.

Rodrigo Valenzuela (R)

Nutrition Department, Faculty of Medicine, University of Chile, Santiago 8380000, Chile.

Alejandra Espinosa (A)

Medical Technology Department, Faculty of Medicine, University of Chile, Santiago 8380000, Chile.

Francisca Echeverría (F)

Nutrition Department, Faculty of Medicine, University of Chile, Santiago 8380000, Chile.

Sandra Soto-Alarcon (S)

Nutrition Department, Faculty of Medicine, University of Chile, Santiago 8380000, Chile.

Cristian Campos (C)

Medical Technology Department, Faculty of Medicine, University of Chile, Santiago 8380000, Chile.

Alicia Rodriguez (A)

Department of Food Science and Chemical Technology, Faculty of Chemical and Pharmaceutical Sciences, University of Chile, Santiago 8380494, Chile.

Romina Vargas (R)

Molecular and Clinical Pharmacology Program, Institute of Biomedical Science, Faculty of Medicine, University of Chile, Santiago 8380000, Chile.

Thea Magrone (T)

Department of Basic Medical Sciences, Neuroscience and Sensory Organs, University of Bari, 70124 Bari, Italy.

Luis A Videla (LA)

Molecular and Clinical Pharmacology Program, Institute of Biomedical Science, Faculty of Medicine, University of Chile, Santiago 8380000, Chile.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH